Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DX3SD2
|
|||
| Drug Name |
TRQ-1501
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Aggressive cancer [ICD-11: 2A00-2F9Z; ICD-10: R45.6; ICD-9: 140-229] | Phase 1/2 | [1] | |
| Haematological malignancy [ICD-11: 2B33.Y] | Phase 1/2 | [1] | ||
| Company |
Torque Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.